AOD 9604 Drug Application for Bone Health AOD 9604 Capsule (Anti Obesity Drug 9604) is an artificially synthesized 16 amino acid peptide derived from the active fragment of human growth hormone (hGH) at positions 177-191 and structurally optimized
These effects may be more pronounced in patients with altered gastric anatomy Pancreatitis risk : Patients should be informed about symptoms of acute pancreatitis (severe abdominal pain, sometimes radiating to the back, with vomiting) and seek immediate medical attention if these occur Gallbladder disease : Increased risk of gallstones and gallbladder-related problems, particularly with substantial weight loss Dehydration and acute kidney injury : Reduced fluid intake combined with gastrointestinal side effects may increase risk of dehydration Nutritional concerns : The combination of reduced stomach capacity and appetite suppression may increase the risk of nutritional deficiencies, particularly protein, vitamin B12, iron, and calcium Hypoglycaemia risk : Especially in patients taking diabetes medications, careful monitoring and dose adjustment may be necessary Diabetic retinopathy : Patients with diabetes should have appropriate eye screening, as rapid improvement in glucose control may temporarily worsen retinopathy Medication absorption : GLP-1 receptor agonists may affect absorption of oral medications due to delayed gastric emptying Pregnancy and contraception : These medications are not recommended during pregnancy or breastfeeding
The path to sustainable weight loss is a nuanced one, requiring careful consideration and, most importantly, personalized medical supervision
10.1046/j.1469-8137.2002.00449_1.x 20 BilecenK.OzturkU
